University of Virginia Library

CONFLICT OF INTEREST EXEMPTION (ADENOSINE THERAPEUTICS, LLC)

WHEREAS, the University of Virginia wishes to enter into sponsored research contracts with Adenosine Therapeutics, LLC, a Virginia Corporation, for developing therapeutic agents; and

WHEREAS, George A. Beller, M.D., Irving L. Kron, M.D., Joel M. Linden, Ph.D., Timothy L. MacDonald, Ph.D., and Gail W. Sullivan, Ph.D., have disclosed in advance their equity interests of four percent, six percent, 25 percent, eight percent and four percent, respectively, in Adenosine Therapeutics, LLC, and the University's entry into a research agreement with Adenosine Therapeutics, LLC, would thereby expose them to violation of the Conflict of Interests Act unless approved by the Board as permitted by §2.1-639.6(C)(7) of the Code of Virginia;

RESOLVED that waiver of conflict of interest of Dr. Beller, Dr. Kron, Mr. Linden, Mr. MacDonald, and Ms. Sullivan is approved by the Board of Visitors in order to permit the University to negotiate and enter into proposed contracts for developing therapeutic agents. This approval is granted provided, as required by the law, the faculty file the required annual disclosure statement of personal interests in Adenosine Therapeutics, LLC, the University files the required annual report concerning the contract with the

Secretary of the Commonwealth, and the appropriate department chairs and deans vigilantly oversee application of University resources in the best interests of the University and in accordance with policy.